Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOK study of SSRI exposure during pregnancy and child development
NL-OMON22808Recruiting
- Sponsor
- n.a.
- Start
- Apr 2007
- Countries
- 1
01
Overview
Open-label trial in major depressive disorder (MDD) (3 arms), sponsored by n.a. Primary endpoints: Quality of general movements in the first week after birth, Quality of general movements at 3 months post-term and 4 more. Started Apr 2007; status: recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON22808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22808.